Client:
Emerging Healthcare Startup – India
Project:
Development of a Rapid Diagnostic Kit for Urinary Tract Infection (UTI)
Objective:
To conceptualize, design, and develop a rapid, point-of-care diagnostic test for UTI that is accurate, easy-to-use, and compliant with IVD (In Vitro Diagnostic) regulatory requirements.
Background:
The client aimed to launch a low-cost, high-sensitivity UTI detection kit for use in primary healthcare centers across rural India. The challenge was balancing performance with affordability while ensuring regulatory compliance.
Challenges:
-
Limited R&D infrastructure with the client
-
Strict time-to-market deadlines (6 months)
-
Need for cold chain-free stability for rural distribution
-
Requirement for CE-IVD compliance
Approach:
1. Concept & Feasibility:
-
Conducted market analysis and clinical requirement gathering
-
Evaluated biomarkers suitable for rapid detection (e.g., leukocyte esterase, nitrite)
-
Performed feasibility screening for lateral flow immunoassay platform
2. Prototype Development:
-
Designed test strip layout using nitrocellulose membrane
-
Optimized antibody conjugation and reagent pads
-
Developed buffer formulations for sample preparation
3. Analytical & Clinical Validation:
-
Conducted sensitivity, specificity, and reproducibility studies
-
Partnered with a diagnostic lab for patient sample testing (n=300+)
4. Stability & Packaging:
-
Accelerated aging and real-time shelf-life studies
-
Designed packaging for humidity protection and room temperature storage
5. Regulatory & Scale-Up:
-
Compiled technical documentation as per IVD standards
-
Transferred process to GMP-certified facility for scale-up
-
Applied for CE marking under self-certification route
Results:
-
Achieved >95% accuracy for UTI detection within 3 minutes
-
Product shelf-life validated for 18 months at ambient temperature
-
Scaled production to 50,000 units/month in 2 months
-
Successfully launched in 6 Indian states and exported to 2 African countries
Impact:
-
Enabled faster diagnosis and treatment at the point of care
-
Reduced diagnostic cost per patient by over 60%
-
Strengthened the client’s brand in affordable healthcare diagnostics